<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04190329</url>
  </required_header>
  <id_info>
    <org_study_id>Frailty-Testing</org_study_id>
    <nct_id>NCT04190329</nct_id>
  </id_info>
  <brief_title>Feasibility of an Extended Test Battery and Influencing Factors for Detecting Frailty</brief_title>
  <official_title>Feasibility of an Extended Test Battery and Influencing Factors for Detecting Frailty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the prospective study is to assess the feasibility of a screening and baseline
      measurement protocol that is planned for a main study (PRÄP-GO) in a collective of 30
      patients ageing 70+ scheduled for elective surgery. Comprehensive geriatric assessment scores
      and modified Fried frailty phenotype component evaluation are performed in all patients at
      baseline before elective surgery. The assessment of cognitive tests is conducted with a
      battery of neuropsychological tests, computer-based tests from the Cambridge
      Neuropsychological Test Automated Battery [CANTAB®] and non-computer based tests. Frailty
      scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) represent robust
      (0), pre-frail (1-2), and frail (3-5) health status. 10 patients without Frailty, 10 patients
      with Pre-Frailty and 10 patients with Frailty should be analyzed in this study and receive
      further comprehensive geriatric assessment testing up to seven days after surgery/discharge
      (before 7 postoperative days).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration to run the test battery</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>The duration of the screening test battery is measured with a stopwatch.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acceptance of test battery</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>The study patient´s acceptance of the screening test battery is measured with a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problems to conduct the test battery</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>Problems while performing the test battery are categorized according to a standardized protocol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain</measure>
    <time_frame>Baseline, day 3 after surgery and discharge or day 7 after surgery</time_frame>
    <description>Pain is measured with a pain score, a higher score indicates more pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intelligibility of the patient Diary 1</measure>
    <time_frame>Up to day 7 after surgery</time_frame>
    <description>Number of completed items</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intelligibility of the patient Diary 2</measure>
    <time_frame>Up to day 7 after surgery</time_frame>
    <description>Number of completed days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intelligibility of the patient Diary 3</measure>
    <time_frame>Up to day 7 after surgery</time_frame>
    <description>Coherence of the diary with clinical patient record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implementation rate of the patient Diary 3</measure>
    <time_frame>Up to day 7 after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>Baseline, day 3 after surgery and discharge or day 7 after surgery</time_frame>
    <description>Handgrip strength measured using a Dynamometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobility</measure>
    <time_frame>Baseline, day 3 after the operation and discharge or day 7 after surgery</time_frame>
    <description>Mobility is measured using the Charité Mobilitäts-Index (CHARMI®).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status 1</measure>
    <time_frame>Baseline and discharge or day 7 after surgery</time_frame>
    <description>Nutritional status 1 is measured using serum albumin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status 2</measure>
    <time_frame>Baseline and discharge or day 7 after surgery</time_frame>
    <description>Nutritional status 2 is measured using arm circumference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status 3</measure>
    <time_frame>Baseline and discharge or day 7 after surgery</time_frame>
    <description>Nutritional status 3 is measured using calf circumference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status 4</measure>
    <time_frame>Baseline and discharge or day 7 after surgery</time_frame>
    <description>Nutritional status 4 is measured using the Mini Nutritional Assessment - Short Form (MNA®-SF).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra- and postoperative organ complications</measure>
    <time_frame>Up to 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of intensive care unit stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 1 day.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 7 days.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Cognitive Status</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>Neuropsychological testing</description>
  </other_outcome>
  <other_outcome>
    <measure>Depression</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>The assessment of Depression is measured with the - Patient Health Questionnaire (PHQ-8)</description>
  </other_outcome>
  <other_outcome>
    <measure>Frailty</measure>
    <time_frame>1 day (Once only at screening)</time_frame>
    <description>Frailty is operationalized using modified Fried frailty criteria. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) represent robust (0), pre-frail (1-2), and frail (3-5) health status.</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Frailty Syndrome</condition>
  <arm_group>
    <arm_group_label>10 non-frail (robust) study patients</arm_group_label>
    <description>Patients fulfill 0 criteria according to modified Fried frailty score.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 pre-frail study patients</arm_group_label>
    <description>Patients fulfill 1-2 criteria criteria according to modified Fried frailty score.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 frail study patients</arm_group_label>
    <description>Patients fulfill 3, 4 or 5 criteria according to modified Fried frailty score.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective surgery aged ≥70 years, including 10 patients without Frailty,
        10 patients with Pre-Frailty and 10 patients with Frailty.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age ≥ 70 years

          -  Male and female patients

          -  Patient eligible for inclusion: by the patient, preoperatively

          -  elective surgery

          -  Expected anesthesia duration&gt; 60min

        Exclusion criteria:

          -  Severe cardiological or pulmonary disease (NYHA IV, Gold IV)

          -  Intracranial interventions

          -  Moribund patients (palliative situation)

          -  Not enough language skills

          -  Non-consenting patients

          -  Participation in another prospective intervention study for study inclusion or
             throughout the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité Univerisitätsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudia Spies, MD Prof.</last_name>
    <phone>+49 30 450 55 11 02</phone>
    <email>claudia.spies@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Spies, MD, Prof.</last_name>
      <phone>+49 30 450 551001</phone>
      <email>claudia.spies@charite.de</email>
    </contact>
    <investigator>
      <last_name>Claudia Spies, MD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fatima Yürek, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Friedrich Borchers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Björn Weiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rudolf Mörgeli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Hadzidiakos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jörn Kiselev</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katrin Schmidt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>December 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

